title: Is there a role for generic antiretroviral drugs in the United States?
abstract: The high cost of antiretroviral drugs has limited access to treatment for some HIV-infected patients in the United States and strained public resources. With the introduction of much cheaper generic versions of some of these agents, and with more to come in the next few years, the need increases to define the role of generic antiretroviral drugs in patient management.
authors.affiliation: Division of Infectious Diseases, New York Medical College, Skyline Office #2NC20, 40 Sunshine Cottage Road, Valhalla, NY 10595, USA.
authors.forename: Gary P
authors.initials: GP
authors.lastname: Wormser
authors.forename: Thomas
authors.initials: T
authors.lastname: Lappas
mesh_terms: D019380:Anti-HIV Agents / Q000191:economics* / Q000592:standards / Q000600:supply & distribution / Q000627:therapeutic use; D003695:Delivery of Health Care / Q000191:economics / Q000458:organization & administration; D016527:Drug Costs; D016568:Drugs, Generic / Q000191:economics* / Q000592:standards / Q000600:supply & distribution / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019380:Anti-HIV Agents; D016568:Drugs, Generic
keywords: antiretroviral; drug; generic; treatment; virus